FDA Approval for Moderna's Flu Vaccine: A Cautionary Tale of Science vs Politics The US Food and Drug Administration (FDA) recently approved Moderna's mRNA seasonal flu vaccine, mFlusiva.
This approval marks a significant development in immunology, but the journey to this milestone was marred by controversy and a lack of transparency from the FDA.
Influenza remains one of the leading causes of morbidity and mortality worldwide, with up to five million severe cases and 650,000 respiratory deaths annually.